These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18988557)

  • 1. Coming soon to your lab: NAF for breast-cancer risk assessment.
    Bentz J
    MLO Med Lab Obs; 2008 Oct; 40(10):52-3. PubMed ID: 18988557
    [No Abstract]   [Full Text] [Related]  

  • 2. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
    Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
    Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal lavage in the screening of high-risk women.
    Kenney PJ; Ellison MC
    Curr Womens Health Rep; 2003 Apr; 3(2):151-5. PubMed ID: 12628085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
    Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal lavage and its histopathologic basis: a cautionary tale.
    Badve S
    Diagn Cytopathol; 2004 Mar; 30(3):166-71. PubMed ID: 14986296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of nipple fluid for breast cancer screening.
    Suijkerbuijk KP; van der Wall E; Vooijs M; van Diest PJ
    Pathobiology; 2008; 75(2):149-52. PubMed ID: 18544970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytodiagnosis of breast neoplasms using nipple discharge].
    Matsuda M
    Rinsho Byori; 1985 Jul; Spec No 64():35-58. PubMed ID: 3906184
    [No Abstract]   [Full Text] [Related]  

  • 11. Nipple aspirate cytology for the study of breast cancer precursors.
    King EB; Chew KL; Petrakis NL; Ernster VL
    J Natl Cancer Inst; 1983 Dec; 71(6):1115-21. PubMed ID: 6581355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: ductal lavage of the breast.
    Linder J
    Diagn Cytopathol; 2004 Mar; 30(3):140-2. PubMed ID: 14986292
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry.
    He J; Gornbein J; Shen D; Lu M; Rovai LE; Shau H; Katz J; Whitelegge JP; Faull KF; Chang HR
    Int J Oncol; 2007 Jan; 30(1):145-54. PubMed ID: 17143523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal lavage and risk assessment of breast cancer.
    Arun B
    Oncologist; 2004; 9(6):599-605. PubMed ID: 15561804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal lavage: clinical utility and future promise.
    O'Shaughnessy JA
    Surg Clin North Am; 2003 Aug; 83(4):753-69, vii. PubMed ID: 12875594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-tissue sampling for risk assessment and prevention.
    Fabian CJ; Kimler BF; Mayo MS; Khan SA
    Endocr Relat Cancer; 2005 Jun; 12(2):185-213. PubMed ID: 15947097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nipple-aspirate fluid cytology in breast-cancer risk screening.
    Bentz J
    MLO Med Lab Obs; 2009 Mar; 41(3):8, 10, 12-7. PubMed ID: 19374177
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of 2,6-cyclolycopene-1,5-diol in breast nipple aspirate fluids and plasma: a potential marker of oxidative stress.
    Chen G; Djuric Z
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1592-6. PubMed ID: 12496049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of breast ductoscopy in breast cancer screening.
    Sarakbi WA; Escobar PF; Mokbel K
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):208-11. PubMed ID: 16468470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple fluid cytology.
    Masood S; Khalbuss WE
    Clin Lab Med; 2005 Dec; 25(4):787-94, vii-viii. PubMed ID: 16308092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.